Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam-sevoflurane vs propofol-sevoflurane balanced anesthesia in major spine surgery
ChiCTR2500102262Phase 4Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoint: Incidence of delayed emergence. Started May 2025; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2500102262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102262.